The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: S&P And Shore Upgrade Aviva After Strong Half

Fri, 05th Aug 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning and Thursday:
----------
FTSE 100
----------
DEUTSCHE BANK RAISES RANDGOLD RESOURCES TARGET TO 7370 (7100) PENCE - 'HOLD'
----------
GOLDMAN CUTS SHELL B PRICE TARGET TO 2230 (2250) PENCE - 'CONVICTION BUY LIST'
----------
INDEPENDENT RESEARCH RAISES ANGLO AMERICAN TARGET TO 910 (840) PENCE - 'HOLD'
----------
JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 1770 (1760) PENCE - 'BUY'
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2955 (2400) P - 'EQUAL WEIGHT'
----------
JEFFERIES CUTS WOLSELEY TO 'HOLD' ('BUY') - TARGET 4180 (3980) PENCE
----------
SOCGEN CUTS NEXT PRICE TARGET TO 5695 (7133) PENCE - 'HOLD'
----------
JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 8300 (6800) PENCE - 'BUY'
----------
S&P GLOBAL CUTS HIKMA PHARMACEUTICAL TO 'HOLD' ('BUY') - TARGET 2400 PENCE
----------
UBS RAISES RSA INSURANCE PRICE TARGET TO 496 (456) PENCE - 'NEUTRAL'
----------
S&P GLOBAL RAISES AVIVA TO 'BUY' ('HOLD') - TARGET 450 (500) PENCE
----------
Shore Capital Upgrades Aviva To Hold From Sell
----------
UBS RAISES OLD MUTUAL PRICE TARGET TO 230 (210) PENCE - 'BUY'
----------
S&P GLOBAL RAISES STANDARD CHARTERED TO 'HOLD' (SELL) - PRICE TARGET 650 (480) PENCE
----------
UBS CUTS BT GROUP PRICE TARGET TO 425 (450) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
Numis Ups Tullow Oil To Hold From Reduce, Target To 200p From 190p
----------
Numis Ups Cairn Energy To Add From Hold, Keeps Target At 210p
----------
UBS RAISES CAIRN ENERGY TO 'BUY' ('NEUTRAL') - TARGET 220 PENCE
----------
S&P GLOBAL RAISES AGGREKO PRICE TARGET TO 950 (900) PENCE - 'SELL'
----------
PANMURE RESUMES RPC GROUP WITH 'BUY' - TARGET 1156 PENCE
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 150 (154) PENCE - 'HOLD'
----------
JEFFERIES RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 430 (400) PENCE - 'HOLD'
----------
JEFFERIES RAISES GRAFTON GROUP PRICE TARGET TO 680 (620) PENCE - 'BUY'
----------
S&P GLOBAL CUTS SERCO GROUP TO 'HOLD' ('BUY') - TARGET 140 (115) PENCE
----------
MAIN MARKET AND AIM
----------
Numis Resumes Hornby At Buy, Price Target At 38p
----------
Investec Cuts Nichols To Hold From Buy, Ups Target To 1,472p From 1,450p
----------
Liberum Ups IFG Group Target To 220p From 215p, Keeps Buy
----------
UBS RAISES SOCO INTERNATIONAL PRICE TARGET TO 160 (145) PENCE - 'NEUTRAL'
----------
UBS RAISES PETRA DIAMONDS PRICE TARGET TO 150 (140) PENCE - 'BUY'
----------
By Lucy Heming; lucyheming@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.